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Because efficient trafficking of immune cells 
to the gastrointestinal (GI) tract is critical for 
host defense against pathogenic challenge, study­
ing cellular recruitment pathways to the GI 
tract is the key to developing novel vaccines 
against mucosally transmitted diseases, including 
HIV­1 infection.
Naive T cells acquire the capacity to migrate 
to extra­lymphoid tissues once activated by 
their cognate antigen (Butcher et al., 1999; von 
Andrian and Mackay, 2000). These antigen­ 
experienced effector T cells migrate preferen­
tially to the tissues where they first encountered 
the antigen (Kantele et al., 1999; Campbell and 
Butcher, 2002). For example, early observations 
demonstrated that cells activated in the GI tract 
home back to the intestinal effector sites (Cahill 
et al., 1977; Hall et al., 1977). Integrin 47 
and chemokine receptor 9 (CCR9) are among 
the best studied gut­specific homing molecules 
(Berlin et al., 1995; Zabel et al., 1999). The 
47 ligand mucosal addressin cell adhesion 
molecule­1 (MAdCAM­1) mediates recruit­
ment of T cells to the intestinal lamina propria 
(Berlin et al., 1995), and the CCR9 ligand TECK, 
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Developing efficacious vaccines against enteric diseases is a global challenge that requires a 
better understanding of cellular recruitment dynamics at the mucosal surfaces. The current 
paradigm of T cell homing to the gastrointestinal (GI) tract involves the induction of 47 
and CCR9 by Peyer’s patch and mesenteric lymph node (MLN) dendritic cells (DCs) in a 
retinoic acid–dependent manner. This paradigm, however, cannot be reconciled with reports 
of GI T cell responses after intranasal (i.n.) delivery of antigens that do not directly target 
the GI lymphoid tissue. To explore alternative pathways of cellular migration, we have 
investigated the ability of DCs from mucosal and nonmucosal tissues to recruit lymphocytes 
to the GI tract. Unexpectedly, we found that lung DCs, like CD103+ MLN DCs, up-regulate 
the gut-homing integrin 47 in vitro and in vivo, and induce T cell migration to the GI 
tract in vivo. Consistent with a role for this pathway in generating mucosal immune  
responses, lung DC targeting by i.n. immunization induced protective immunity against 
enteric challenge with a highly pathogenic strain of Salmonella. The present report demon-
strates novel functional evidence of mucosal cross talk mediated by DCs, which has the 
potential to inform the design of novel vaccines against mucosal pathogens.
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it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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lamina propria (SILP; Esplugues et al., 2011). Furthermore, 
Ciabattini et al. (2011) have demonstrated that after i.n. 
immunization, antigen­specific T cells are generated in the 
mediastinal LN and migrate to the MLN in an 47­ and 
CD62L­dependent manner. Additionally, it is known that lungs 
harbor prominent extrahepatic stores of vitamin A (Okabe 
et al., 1984; Dirami et al., 2004). Its metabolite, RA, plays an 
important role in pulmonary alveolar development (Dirami 
et al., 2004) and has a putative therapeutic role in emphy­
sema (Massaro and Massaro, 1997). Finally, although RA pro­
duction has been considered to be the forte of gut­resident 
DCs, other DC populations also express RALDH, particu­
larly lung­resident DCs that express RALDH­2 (Heng and 
Painter, 2008; Guilliams et al., 2010). However, the ability of 
lung DCs to induce GI­specific T cell homing has not yet 
been reported.
All of the aforementioned factors led us to hypothesize that 
lung DCs would up­regulate the expression of gut­homing 
molecules integrin 47 and CCR9 on T cells, which in 
turn would license the migration of T cells to the GI tract. 
Our hypothesis was made credible by the concept of a com­
mon mucosal immunological system proposed by Bienenstock 
et al. (1978) more than 30 years ago. Indeed, there is increasing 
appreciation of the mucosal immune system as an integrated 
network of tissues, cells, and effector molecules, although the 
cellular factors that link different mucosal compartments are 
not well understood (Gill et al., 2010).
In this study, we show that lung DCs can imprint expres­
sion of the gut­homing integrin 47 and CCR9 on co­
cultured T cells in vitro and on adoptively transferred cells 
in vivo, licensing T cells to migrate to the GI lamina propria 
and confer protective immunity against intestinal pathogens. 
We define a new pathway of DC­mediated mucosal cross talk 
and challenge the existing dogma that only GI­resident DCs 
can recruit antigen­specific T cells back to the gut.
RESULTS
Lung DCs induce expression of integrin 47  
and CCR9 on T cells in vitro and in vivo
We conducted a screen to examine the ability of mucosal 
and nonmucosal DCs to induce gut­homing integrin­47 
and CCR9 expression. CD11c+ cells were isolated from 
murine lung, spleen (SpDC), MLNs, and skin­draining LNs 
(SkDC) and co­cultured with CFSE­labeled T cells from 
OVA­reactive CD4+ T cells from OT­II mice at a ratio of 
1:2 DC/T cells for 5–7 d. Unexpectedly, we observed that 
the expression of integrin 47 and CCR9 was significantly 
up­regulated by lung DCs, similar to MLN DCs, with 47 
and CCR9 up­regulation most prominent on proliferating 
(CFSElo) cells (Fig. 1, a–c).
To test whether lung DCs can up­regulate 47 in vivo, 
we adoptively transferred CFSE­labeled CD45.1+ OT­II cells 
to naive CD45.2 mice and immunized the mice after 2 h 
with OVA protein and polyICLC delivered i.n., s.c., i.t., or 
orally (per os; p.o.). On day 4 after immunization, the per­
centage of CD45.1+V2+CD4+CFSElo cells expressing 47 
expressed by small intestinal epithelial cells, recruits T cells to the 
small bowel (Zabel et al., 1999).
DCs are well recognized as the initiators of the adaptive 
immune response (Steinman and Cohn, 1973), as well as me­
diators of tolerance to self­antigens in steady­state conditions 
(Hawiger et al., 2001). Additionally, there is increasing evi­
dence regarding the role played by DCs as conductors of 
immunological traffic to the skin and the GI tract ( Johansson­ 
Lindbom et al., 2003, 2005; Mora et al., 2003, 2005; 
Sigmundsdottir et al., 2007). DCs can imprint T cells to mi­
grate to the tissue in which the T cells were originally activated. 
For example, gut­associated DCs induce the gut­homing re­
ceptors 47 and CCR9 on T cells upon activation ( Johansson­ 
Lindbom et al., 2003; Mora et al., 2003; Stagg et al., 2002).
RA is necessary and sufficient to induce gut­homing 
receptors on T cells (Iwata et al., 2004). The main pathway of 
RA biosynthesis in vivo is dependent on the intracellular oxi­
dative metabolism of retinol (Napoli, 1999; Duester, 2000), 
catalyzed by a family of alcohol dehydrogenases including 
retinal dehydrogenase (RALDH), a class I aldehyde dehydrog­
enase that mediates the irreversible oxidation of retinal to 
RA. RA in turn is thought to induce RALDH­2 in a positive 
feedback loop (Yokota et al., 2009; Hammerschmidt et al., 
2011; Villablanca et al., 2011) and RA levels correlate with 
the ability of the intestinal DCs to induce gut­tropic T cells. 
Vitamin A is introduced via dietary or biliary sources ( Jaensson­
Gyllenbäck et al., 2011). Among the cellular sources of RA 
in the intestinal mucosa are DCs (Iwata et al., 2004), stromal 
cells (Hammerschmidt et al., 2008; Molenaar et al., 2009), 
intestinal epithelial cells (Bhat, 1998; Lampen et al., 2000), 
and intestinal macrophages (Denning et al., 2007), with the 
DCs likely playing a key role in the induction of gut­homing 
phenotype on T cells. Among the intestinal DCs, the CD103+ 
DC subsets express high levels of RALDH­2 and are capable of 
generating high levels of RA (Johansson­Lindbom et al., 2005; 
Coombes et al., 2007; Sun et al., 2007; Jaensson et al., 2008). 
In contrast, the CD103CD11b+CX3CR1+ macrophage­
like population in the intestinal lamina propria expresses 
RALDH­1 and not RALDH­2 and exhibits a lower RA­
producing capacity (Schulz et al., 2009; Denning et al., 2011), 
and therefore a decreased capacity to induce gut­homing 
potential on T cells ( Jaensson et al., 2008).
Collectively, a paradigm has emerged wherein only the 
intestinal CD103+ DCs, which are capable of metabolizing 
vitamin A, can induce GI­specific homing on T cells (Jaensson 
et al., 2008). This paradigm however, is difficult to reconcile 
with reports of GI T cell responses after i.n. delivery of anti­
gens that do not directly target the GI lymphoid tissue. For 
example, mice infected i.n. with influenza virus show no 
activated virus­specific CD8+ T cells in the mesenteric LNs 
(MLNs) or Peyer’s patches (PPs), yet flu­specific CD8+ cells 
within the lung­associated tissues express 47 and memory 
CD8+ T cells are established within the small intestinal epi­
thelium (Masopust et al., 2010). Similarly, a recent study dem­
onstrates that i.n. challenge with H1N1 influenza results in 
the accumulation of TH17 cells within the small intestinal 
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and CD11b+CD103 DC populations and co­cultured with 
CFSE­labeled OT­II cells. Unexpectedly, both CD103+ 
CD11b and CD11b+CD103 lung DC subsets induced 47 
integrin, with expression of 47 being even higher in the 
CD11b+CD103 populations. As previously described (Jaensson 
et al., 2008), among the MLN DCs, CD103+CD11b DCs 
induced high levels of 47, whereas CD11b+CD103 DCs 
did not (Fig. 2, a and b). Additionally, the lung CD11b+CD103 
population was sorted into CD24+CD64 and CD24CD64+ 
was determined in the blood, lung, and spleen. As shown 
in Figs. 1 (d and e), a significantly higher percentage of 
CFSElo47+ cells were induced in the blood, lung, and spleen 
after i.n., i.t., and p.o. immunization than in the blood or 
spleen after s.c. immunization. Similar findings were observed 
in the case of CD8+OT­I cells (unpublished data).
We next examined the ability of lung DC subsets to in­
duce 47. Lung MHC­II+CD11chi DCs (gating strategy 
shown in Fig. S1) were FACS­sorted into CD103+CD11b 
Figure 1. Lung DCs induce integrin 
47 and CCR9. (A–C) CD11c+ DCs isolated 
from the lung, spleen, skin-draining LNs, or 
MLNs were pulsed with OVA and cultured 
with CFSE-labeled OT-II T cells at a ratio of 1:2 
for 5–7 d. (A) T cell expression of 47 (top) 
and CCR9 (bottom) was measured by flow 
cytometry and plotted against CFSE dilution. 
(B and C) Quantification of the number of 
proliferated (CFSElo) 47+ (B) or CCR9+ (C) 
cells showing cumulative data from three 
independent experiments. (D and E) CFSE-
labeled CD45.1+V2+CD4+OT-II cells were 
transferred into naive CD45.2+ recipients. 2 h 
after transfer, mice were immunized with OVA 
protein + polyICLC or cholera toxin via the 
indicated route, and the percentage of 
CFSEloCD45.1+V2+CD4+ cells expressing 
47 was determined in blood, lung, and 
spleen 4 d after immunization. (D) Represen-
tative flow cytometry data showing CFSE 
dilution versus 47 expression. (E) Cumula-
tive data from three independent experiments 
showing frequency of 47+CFSElo cells 
among total V2+CD4+ cells.
1874 Lung dendritic cells' intestinal homing | Ruane et al.
targeted in the mediastinal LNs and lungs, with the peak 
labeling occurring 24 h after antibody administration. How­
ever, we could not detect antibody­labeled cells in the spleen, 
MLN, or the GI tissues even after 72 h. To rule out a possible 
role of gastric acid or GI proteases, cleaving the injected anti­
bodies, orally delivered CD11c was administered to C57BL/6 
mice. Peak labeling was detected in the small intestines after 
16 h, targeting the CD11b+ population (unpublished data). 
Therefore, transport of labeled antibodies through the GI 
tract does not affect its ability to be used to stain gut DCs in 
vivo. To confirm this, we compared i.n. and intratracheal (i.t.) 
delivery of fluorescent antibodies and found that i.t. immuni­
zation targets DCs in the lung similar to those targeted by i.n. 
immunization (unpublished data).
We next conducted a time course experiment to study the 
kinetics of induction of integrin 47 and the migration of 
adoptively transferred cells into the GI tissues: SILP, colon, and 
MLNs. CFSE­labeled CD45.1+ OT­II cells were adoptively 
transferred to naive CD45.2 recipients that were immunized 
after 2 h with OVA protein and polyICLC­delivered i.n. We 
populations. We used these markers to distinguish between 
macrophages and DCs contained within the heterogeneous 
CD11b+ population (Langlet et al., 2012; Tamoutounour 
et al., 2012). Additionally, although not the focus of this study, 
a combination of MAR­1 and CD64 can also be used to dis­
tinguish between cDCs and MoDCs contained within the 
CD11b population (Plantinga et al., 2013). We observed strik­
ing differences between the CD24+ and CD64+ subpopula­
tions, with the CD11b+CD24+ cells inducing both integrin 
47 and CCR9. In contrast, the CD11b+CD64+ popula­
tion was poor in inducing both T cell proliferation and gut­
homing molecule induction (Fig. 2, c–e).
Lung DCs license T cells to migrate  
to the intestinal lamina propria via 47 induction
Targeting of lung DCs by i.n. delivery (Vermaelen et al., 
2001) was confirmed in a time course experiment (unpub­
lished data) where fluorescently labeled antibodies directed 
against CD11c were administered to C57BL/6 mice i.n. Both 
CD103+CD11b and CD11b+CD103 DC subsets were 
Figure 2. Lung CD103+ and CD24+11b+ DCs 
induce integrin 47 and CCR9 in vitro. (A and  
B) MHCII+CD11chiCD11b+CD103 and MHCII+CD11chi
CD11bCD103+ DCs were flow-sorted from the lung 
or MLN, pulsed with OVA, and cultured with CFSE-
labeled OT-II T cells at a ratio of 1:2 for 5–7 d.  
(A) T cell expression of 47 induced by lung DCs (top) 
and MLN DCs (bottom) was measured by flow cytom-
etry and plotted against CFSE dilution. (B) Quantifica-
tion of the number of proliferated (CFSElo) 47+ 
cells showing cumulative data from three indepen-
dent experiments. (C–E) Lung-derived MHCII+CD11chi
CD103CD11b+CD24+ and MHCII+CD11chiCD103 
CD11b+CD64+ cells were flow-sorted. Additionally, 
MHCII+CD11chi DCs were isolated from skin-draining 
LNs. These DCs were pulsed with OVA and cultured 
with CFSE-labeled OT-II T cells at a ratio of 1:2 for  
5–7 d (C) T cell expression of 47 (top) and CCR9 
(bottom) was measured by flow cytometry and plotted 
against CFSE dilution. (D and E) Quantification of the 
number of proliferated (CFSElo), 47+ (D) or CCR9+ 
(E) cells showing cumulative data from three inde-
pendent experiments.
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to the peak expression of integrin 47 on lung and mediasti­
nal LN–resident transferred cells. Additionally, we did not de­
tect proliferation of the CFSE­labeled CD45.1+ OT­II cells in 
the MLN on days 1, 2, and 3. The earliest site, where T cell pro­
liferation was observed after i.n. immunization, was the medi­
astinal LNs (Fig. 3 c). In contrast, proliferating cells were 
detected in the MLNs by day 4, suggesting that T cell activation 
initially occurred in the mediastinal LNs and not the MLNs.
Next, we wanted to confirm that the transferred 
CD45.1+V2+CD4+ T cells detected in the GI tissues after 
tested for the induction of integrin 47 on the transferred 
cells on days 1, 2, 3, 4, and 7 after transfer and quantified the 
frequency of transferred cells in GI tissues at the same time 
points (Fig. 3, a and b). Proliferation of the transferred cells was 
first detected in the mediastinal LNs on day 2 after transfer. On 
day 3, a sharp rise in the expression of integrin 47 was noted 
on the transferred cells in the mediastinal LNs and the lungs, 
peaking at day 4 and regressing by day 7. The frequency of trans­
ferred CD45.1+V2+CD4+ T cells showed a striking rise on 
day 4 in the GI tissues (SILP, colon, and MLNs) corresponding 
Figure 3. After i.n. immunization, inte-
grin 47 is induced in the mediastinal 
LN- and lung-resident cells, followed by 
the appearance of migratory cells in the 
GI tissues. CD45.1+V2+CD4+OT-II cells were 
transferred into naive CD45.2+ recipients. 2 h 
after transfer, mice were immunized with OVA 
protein + polyICLC via the i.n. route, and the 
transferred CD45.1+V2+CD4+ cells in medias-
tinal LN (med LN), lung, SILP, colon, and MLN 
were examined on days 1, 2, 3, 4, and 7 after 
immunization. (A) Representative flow cytom-
etry data showing CFSE dilution versus 47 
expression in the med LN and lung at the 
respective time points (top two rows) and  
the frequency of adoptively transferred 
V2+CD45.1+CD4+ T cells in the SILP, colon 
and MLN (bottom three rows). (B) Cumulative 
data showing frequency of 47+CFSElo cells 
among total V2+CD4+ cells (left) and the 
frequency of V2+CD45.1+ cells among total 
CD4+ T cells (right). (C) Proliferation (CFSE 
dilution) of the adoptively transferred 
CD45.1+CD4+V2+ T cells is compared be-
tween the med LN (top) and MLN (bottom) of 
the recipient mice on days 1, 2, 3, 4, and 7.
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compartments in the FTY­treated group. Thus, based on the 
in vivo labeling, time course, and FTY experiments, we were 
able to conclude that after i.n. delivery of antigen, integrin 
47 was induced on transferred T cells within the mediastinal 
LNs and lungs and that inadvertent swallowing of i.n.­delivered 
antigen was not a factor in our experimental system.
Next, we sought to compare the efficiency of lung DC–
primed and skin DC–primed T cells to migrate to the GI 
tract. Mice were immunized i.n. or s.c. (2 h after adoptive 
transfer of CFSE­labeled CD45.1+ OT­II cells to naive 
CD45.2+ mice) with OVA protein and polyICLC. On day 7, 
after immunization, the frequency of CD45.1+V2+ cells 
in the small intestines and colon was 3–10 fold higher after 
i.n. immunization than after s.c. immunization, demonstrating 
that lung DC–primed congenic OT­II cells migrated to the 
lamina propria with a significantly greater efficiency than skin 
DC–primed OT­II cells (Fig. 5, a and b).
We next sought to examine the effect of blocking integrin 
47 on lung DC–primed, 47­expressing cells to the GI 
tract. After adoptive transfer of CFSE­labeled CD45.1+OT­II 
cells and i.n. immunization with OVA/polyICLC, half of the 
i.n. immunization were being generated in the lung­draining 
LNs and not gut­draining LNs as a result of inadvertent swal­
lowing of i.n.­delivered antigen. We used FTY­720, an in­
hibitor of lymphocyte egress from LNs (Fig. 4) whereby 
CFSE­labeled CD45.1+ OT­II cells were adoptively trans­
ferred to naive CD45.2 recipients that were immunized after 
2 h with OVA protein and polyICLC­delivered i.n. On days 
0–3, recipient mice were administered FTY­720 (1 µg/g 
mouse). The mice were sacrificed on day 4, and the frequency 
of transferred CD45.1+V2+CD4+ T cells was quantified in 
the mediastinal LNs, MLNs, SILP, and colon. An increase in 
the frequency of transferred cells was noted in the mediastinal 
LNs. In contrast, we noted a decrease in the frequency of 
transferred cells in the MLNs, suggesting that antigen expo­
sure and expansion of the transferred OT­II cells was occur­
ring in the mediastinal LNs and not MLNs. As expected, a 
significant decrease in the frequency of transferred cells was 
noted in SILP and colon due to their arrest within the medi­
astinal LN (Fig. 4, a and b). Furthermore, as shown in Fig. 4 c, 
in the absence of gut exposure, the frequency of CFSElo  
antigen­specific T cells was dramatically lowered in the gut 
Figure 4. Administration of FTY-720 
leads to accumulation of transferred 
CD45.2+V2+CD4+ OT-II cells in the me-
diastinal LNs, but not in the MLNs, after 
i.n. vaccination. CFSE-labeled CD45.1+ 
V2+CD4+OT-II cells were adoptively trans-
ferred to naive CD45.2+ recipients that were 
immunized after 2 h with OVA protein and 
polyICLC, delivered i.n. On days 0–3, the re-
cipient mice were administered FTY-720  
(1 µg/g mouse). The mice were sacrificed  
on day 4, and the frequency of transferred 
CD45.1+V2+CD4+ T cells was quantified in 
the med LN, MLN, SILP, and colon. (A) Repre-
sentative flow cytometry plot comparing the 
frequency of adoptively transferred CD45.1+ 
CD4+ V2+ OT-II cells between WT mice (top) 
and FTY-720 administered mice (bottom).  
(B) Quantification of the number of trans-
ferred CD45.1+CD4+V2+ OT-II cells in the 
med LN, MLN, SILP, and colon showing cumu-
lative data from three independent experi-
ments. *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
(C) Proliferation of the adoptively transferred 
CD45.1+CD4+V2+ T cells is compared be-
tween WT and FTY-720 administered mice in 
the indicated tissues.
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Lung DC–mediated induction of integrin 47  
is RA- and TGF-–mediated
RA has an unequivocal role in inducing 47 (Iwata et al., 
2004) and CD103+ DCs from PPs, and MLNs are capable of 
metabolizing vitamin A into RA (Johansson­Lindbom et al., 
2005). To investigate the mechanisms mediating integrin 47 
induction by lung DCs, we started by determining the pres­
ence of retinal to RA­oxidizing enzymes, aldehyde dehydrog­
enases (ALDHs) in lung DCs, using a fluorescent ALDH 
substrate called ALDEFLOUR(Yokota et al., 2009). Both 
CD103+CD11b and CD103CD11b+ lung DC subsets 
mice received 100 µg of anti­47 antibody delivered i.p. on 
days 0 and 3, with the other half receiving PBS as a control. 
As shown in Fig. 5 (c and d), anti­47 antibody administra­
tion led to a significant reduction in the migration of CD4+ 
T cells to the small intestinal and colonic lamina propria, 
as well as the intraepithelial compartments. Conversely, an 
increase in the percentage of CD45.1+V2+CD4+ T cells 
was noted in systemic sites such as the blood, spleen, and 
lung where 47 is not required for cellular migration. This 
demonstrated that i.n. immunization­induced OT­II cell 
migration to the GI tract was mediated by 47.
Figure 5. i.n. immunization–induced migration of T cells to the GI tract is integrin 47-dependent and is more efficient than s.c. immunization–
induced T cell migration to the GI tract. (A and B) 2 h after adoptive transfer of CFSE-labeled CD45.1+V2+CD4+ OT-II cells to naive CD45.2+ mice,  
the recipient mice were immunized i.n. or s.c. with OVA protein and polyICLC. On day 7 after immunization, the frequency of CD45.1+V2+CD4+ T cells 
was determined in the SILP, colon, and MLN. Representative flow cytometry plots (A) and cumulative data from three independent experiments  
(B) are shown. (C and D) After 2 h of adoptive transfer of CFSE-labeled CD45.1+V2+CD4+ OT-II cells to naive CD45.2+ mice, the recipient mice were im-
munized i.n. with OVA protein and polyICLC. On days 0 and 3, mice received 100 µg of anti-47 antibody delivered i.p. with the control mice receiving 100 µl  
of PBS i.p. On day 7 after immunization, the frequency of CD45.1+V2+CD4+ T cells was determined in the colon, IEL, SILP, MLN, blood, spleen, med LN, 
and lung. Representative flow cytometry plots (C) and cumulative data from three independent experiments comparing anti-47 and PBS administered 
mice (D) are shown.
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on 47 induction. Adding 1 µM RAR­ inhibitor LE540 to 
DC/OT­II cultures resulted in a significant reduction of 47 
expression (Figs. 6, b and c). To test for RAR and TGF­  
signaling in vivo, we used a dominant­negative RAR (dnRAR) 
mouse crossed to OT­II on a RAG background (Rajaii et al., 
2008; Pino­Lagos et al., 2011), as well as a TGF­Rdef OT­II 
mouse, respectively (see Materials and methods). WT OT­II 
demonstrated the presence of ALDH at levels comparable to 
MLN CD103+CD11b DCs (Fig. 6 a). This is in concurrence 
with data generated by the Immgen Consortium (Heng and 
Painter, 2008) and a similar study by Guilliams et al. (2010), 
although the ability of lung DCs to induce integrin 47 was 
not examined in either of those studies. Next, we investigated 
the impact of inhibiting retinoic acid receptor (RAR) signaling 
Figure 6. Induction of integrin 47 by lung DCs requires RA and TGF- signaling. (A) Demonstration of ALDH activity in lung-derived DCs using 
flow cytometry. The MFI of a fluorescent ALDH substrate was quantified for lung DCs in the presence (top two curves) or absence (middle two curves) of the 
ALDH inhibitor-DEAB. MLN CD103+ DCs and splenic CD8+ DCs served as the positive and negative controls, respectively (bottom two curves). (B and C) 
CD11c+ DCs isolated from the lung and MLN were pulsed with OVA and cultured with CFSE-labeled OT-II T cells at a ratio of 1:2 for 5–7 d. RAR- inhibitor, 
LE540 (1 µM), or DMSO control is added to the DC/OT-II cultures. (B) Representative flow cytometry plots comparing the expression of 47 on CD4+OT-II 
cells with and without RAR- antagonist LE-540. (C) Quantification of the number of 47+V2+CD4+ T cells induced by the respective DCs, in the absence 
(black bars) or presence (white bars) of RAR- antagonist LE-540. (D) WT CD45.1+V2+CD4+OT-II cells, dnRAR-OT-II cells, and TGF-Rdef OT-II cells (described 
in the Materials and methods) were transferred into CD45.2+ recipient mice and OVA/polyICLC was administered i.n. Cumulative data from three experiments 
comparing the percentage of 47+CFSEloV2+CD4+ T cells between the WT OT-II, dnRAR OT-II, and TGF-Rdef OT-II recipients is shown. (E) After the transfer 
of CD45.1+V2+CD4+OT-II cells, mice were immunized with OVA alone, with OVA + lipopolysaccharide (LPS), with OVA + polyICLC, or with polyICLC alone. 
Cumulative data from three experiments comparing the percentage of 47+CFSEloV2+CD4+ T cells between these mouse groups.
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chimeras (CD11c­DTR bone marrow into WT mice) were 
generated (see Materials and methods) to avoid the lethality 
of DT treatment in CD11c­DTR mice (Zammit et al., 2005). 
24 h after diphtheria toxin (DT) administration, we trans­
ferred CD45.1+ OT­II cells and immunized with OVA/poly­
ICLC. CD11c­DTR mice administered PBS served as controls. 
Significantly lower levels of 47 were induced on the trans­
ferred V2+CD45.1+CD4+CFSElo cells after DT­mediated 
ablation of DCs (Fig. 7, a and b). Because CD11c is also ex­
pressed on various cells, including activated monocytes, macro­
phages, and plasmacytoid DCs (pDCs), the CD11c­DTR 
model cannot definitively distinguish the role of classical DCs 
(cDCs) from activated monocytes and macrophages (Probst 
et al., 2005; Zammit et al., 2005; Bennett and Clausen, 2007) 
in 47 induction. To discern the role of lung cDCs in 47 
induction, we used the recently described zDC­DTR mice 
(Meredith et al., 2012a,b). In these mice, a zinc finger tran­
scription factor, Zbtb46, which is specific to cDCs, is con­
ditionally ablated, thus distinguishing the role of cDCs from 
other cells types expressing CD11c. Again, zDC­DTR chimeras 
(zDC­DTR bone marrow into WT mice) were generated 
(see Materials and methods) to avoid the lethality of DT 
treatment in zDC­DTR mice (Meredith et al., 2012a). 
CD45.1+OT­II cells were transferred into zDC­DTR chimeras 
24 h after DT ablation, and the mice were immunized with 
OVA/polyICLC delivered i.n. zDC­DTR mice adminis­
tered PBS served as controls. Lung DC depletion after DT 
administration was confirmed (unpublished data). Signifi­
cantly lower levels of 47 were induced on the transferred 
cells, dnRAR­OT­II cells, and TGF­Rdef OT­II cells were 
transferred into congenic mice, and OVA/polyICLC was ad­
ministered i.n. We found that 47 induction was attenuated 
on TGF­RdefOT­II cells and virtually absent on dnRAR­ 
OT­II cells, suggesting important roles for TGF­ and RAR 
signaling in lung DC­mediated 47 induction (Fig. 6 d).
Because low levels of integrin 47 can be induced 
by cellular activation, we examined the role of adjuvant in 
47 induction. After CD45.1+OT­II cell transfer into naive 
CD45.2+ hosts, the recipient mice were immunized i.n. with 
OVA alone, OVA/LPS, OVA/polyICLC, and polyICLC 
alone. PolyICLC alone did not induce 47, whereas OVA 
alone did, demonstrating the need for antigen presentation. 
Additionally, OVA/LPS also induced 47, suggesting that 
47 induction was not adjuvant specific (Fig. 6 e).
Finally, to test for involvement of polyICLC­induced 
RIG­I– and TLR3­mediated DC maturation on 47 in­
duction, we transferred CD45.1+OT­II cells into WT and 
MDA­5/TLR3/ hosts (McCartney et al., 2009). No signi­
ficant difference was noted between the MDA­5/TLR3/ 
and WT mice (unpublished data). Thus, we show that expres­
sion of 47 on T cells after i.n. immunization is not induced 
in a nonspecific fashion by polyICLC alone.
After i.n. immunization, induction  
of integrin 47 is mediated by DCs
To test for the role of DCs in the induction of 47 after i.n. 
immunization, we used two different experimental systems. First, 
we used CD11c­DTR mice (Jung et al., 2002). CD11c­DTR 
Figure 7. After i.n. immunization, induction of 
integrin 47 is mediated by DCs. DT was ad-
ministered to CD11c-DTR chimeras (CD11c-DTR 
bone marrow into WT mice), or zDC-DTR chimeras 
(zDC-DTR bone marrow into WT mice) (described in 
the Materials and methods). 24 h later, we trans-
ferred CFSE-labeled CD45.1+V2+CD4+ OT-II cells to 
CD11c-DTR chimeras (A and B) or to zDC-DTR chi-
meras (C and D). Mice administered PBS served as 
the respective controls. Representative flow cytom-
etry plots (A and C) and cumulative data from three 
experiments each (B and D), showing the in vivo 
induction of integrin 47 on CFSEloCD45.1+ 
V2+CD4+ OT-II cells in CD11c-DTR and zDC-DTR 
mice, respectively.
1880 Lung dendritic cells' intestinal homing | Ruane et al.
V2+CD45.1+CD4+CFSElo cells after DT­mediated ablation 
of cDCs (Fig. 7, c and d). Thus, using two different methods 
of DC depletion, we confirmed that lung DCs mediated the 
induction of integrin 47 in vivo.
Ablation of lung CD11b+ cells attenuates  
the induction of 47, whereas depletion  
of langerin+ and Batf-dependent DCs does not
Contrary to the MLN, where only CD103+ DCs (and not 
CD11b+ DCs) up­regulate gut­homing phenotype (Johansson­ 
Lindbom et al., 2005), we have found that both CD103+ 
and CD11b+ lung DC subsets express ALDH (Fig. 6) and 
that both lung DC subsets up­regulated 47 and CCR9 
in vitro (Fig. 1). Here, we wanted to test the effect of ablating 
specific lung DC populations on the induction of 47 
in vivo. To deplete CD11b+ lung DCs, we used CD11b­DTR 
mice (Duffield et al., 2005). CD11b­DTR chimeras were cre­
ated (CD11b­DTR bone marrow into WT mice). Two doses 
of DT (25 ng/g) were administered on days 0 and 1. On 
day 3, CD45.1+ OT­II cells were adoptively transferred, 
and the mice were immunized with OVA and polyICLC. 
4 d later, we examined the transferred cells for 47 induc­
tion. CD11b­DTR chimera that received PBS instead of DT 
served as controls. As shown in Fig. 8 (a and b), the 47 level 
on transferred V2+CD45.1+CD4+CFSElo cells in the blood, 
lung and mediastinal LN were significantly lower in the DT 
injected mice compared with mice that received PBS. Addi­
tionally, we examined the transferred CD45.1+ T cells in the 
spleen and MLN of recipient mice and observed similar at­
tenuation of 47 induction (unpublished data). We tested 
multiple doses of DT and found that two doses of 25 ng/g 
mouse, 1 d apart, were optimal in effecting depletion of 
CD11b+ lung DCs and mediastinal LN DCs (Fig. 8, c and d). 
One dose of DT resulted in monocyte depletion in the blood, 
but not in lung tissue, and three doses of DT were lethal after 
i.n. administration of PolyICLC (unpublished data).
To examine the effect of depleting CD103+ lung DCs, 
we used two systems: temporal (Langerin DTR; Kissenpfennig 
et al., 2005) and constitutive (Batf3/; Hildner et al., 2008). 
In the Langerin DTR mice, 1 d after administration of DT, 
CD45.1+OT­II cells were adoptively transferred and the mice 
were immunized with OVA and polyICLC. 4 d later, we 
examined the transferred cells for 47 induction. Langerin 
DTR mice administered PBS served as controls. There was no 
difference in the levels of 47 between PBS­ and DT­treated 
mice (Fig. 9, a and b). Next, we compared Batf3/ and WT 
mice. Again, after adoptive transfer of congenic OT­II cells 
and immunization with OVA/PolyICLC, no difference was 
observed between the levels of 47 induced on the adoptively 
Figure 8. Ablation of CD11b+ cells attenu-
ates the induction of 47 on transferred 
OT-II cells after i.n. immunization. Two doses 
of DT were administered to CD11b-DTR chimeras 
(CD11b-DTR bone marrow into WT mice; described 
in the Materials and methods) on days 0 and 1. 
On day 3 after DT, CFSE-labeled CD45.1+V2+ 
CD4+ OT-II cells were transferred and the mice 
were immunized i.n. with OVA/polyICLC. PBS-
administered CD11b-DTR mice served as controls. 
Representative flow cytometry plots (A) and  
cumulative data from three independent experi-
ments showing the induction of integrin 47  
on adoptively transferred CD45.1+V2+CD4+ OT-II 
cells in PBS or DT-administered animals (B).  
(C) Representative flow cytometry plots compar-
ing the frequency of MHCII+CD11c+-gated 
CD11c+CD11b+ cells in the lung (top) and med LN 
(bottom) of CD11b-DTR bone marrow chimeric 
mice administered PBS or DT. (D) Quantification 
of CD11b and CD11b+ DC in the lung and med 
LN of CD11b-DTR bone marrow chimeric admin-
istered PBS or DT, showing cumulative data from 
three independent experiments.
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transferred cells (Fig. 9, c and d). Together, these data suggest 
that in vivo, lung CD11b+ DC subsets are more proficient in 
inducing 47 than the CD103+ DCs.
Lung DCs induce protective immunity in the GI tract
Having observed that lung DCs can license T cells to migrate 
to the GI tract, we wanted to examine whether protective gut 
immunity can be induced after targeting of lung DCs by i.n. 
immunization. We first transferred CD45.1+ OT­II cells into 
naive mice and immunized i.n. or s.c., with unimmunized 
mice serving as controls. After gavage of pathogenic Salmonella 
typhimurium expressing OVA, all the unimmunized or s.c.­ 
immunized mice died between days 6–9. In contrast, survival 
in the i.n. immunized mice was prolonged by 2–3 d (unpub­
lished data). Transferred V2+CD45.1+CD4+ T cells were 
enriched in the small and large intestinal lamina propria and 
intraepithelial compartments in the i.n.­immunized mice 
compared with the s.c.­immunized animals (unpublished data). 
Having observed that i.n. immunization extended the sur­
vival of Salmonella­challenged animals in the transgenic OVA 
TCR model, we asked whether a protective immune response 
could be generated from the endogenous immune repertoire. 
WT mice were immunized with OVA/polyICLC (100 µg 
and 50 µg, respectively) delivered i.n. or s.c. in a prime­boost 
fashion or p.o. with OVA/Cholera Toxin (50 mg/ 2 µg; 
a booster dose of the vaccine was given 4 wk after priming), 
and challenged orally with Salmonella­OVA. Survival was 
significantly greater in the i.n.­immunized mice compared 
with unimmunized mice, with 36% of the mice demonstrat­
ing long term survival (>40 d, P < 0.05; Fig. 10 a).Pathologi­
cal examination of the liver, spleen, and MLN demonstrated 
significant disruption of hepatic, splenic, and LN architecture, 
vasculitis, coagulative necrosis, and intravascular thrombi in 
the challenged, unimmunized mice compared with WT mice, 
similar to previous studies (Jones and Falkow, 1996; Griffin and 
McSorley, 2011). In contrast, the liver, spleen, and MLN of i.
n.­immunized mice were indistinguishable from WT mice 
(Fig. 10 b). This is also reflected in the inflammation score 
(Wu et al., 2005) for each of the vaccinated groups (Fig. 10 c). 
Stool cultures showed a significantly higher level of Salmonella 
in the stool of i.n. immunized mice on days 2 and 4 after 
challenge (unpublished data), perhaps because of luminal se­
questration of the bacteria. Interestingly, the i.n.­immunized 
mice showing long term survival continued to demonstrate 
detectable levels of Salmonella in the stool even at day 40 (un­
published data). Finally, we also immunized naive C57BL/6 
mice with heat and paraformaldehyde inactivated Salmonella 
typhimurium, delivered i.n. or s.c. Significantly lower levels of 
Salmonella CFUs were observed in the spleen of i.n.­immunized 
mice compared with unimmunized mice (Fig. 10 d). Thus, 
using three different models of protection against pathogenic 
Salmonella, we found that i.n. immunization extends survival, 
Figure 9. Ablation of CD103+ DCs does not 
impact the induction of 47 on transferred 
OT-II cells after i.n. immunization. (A and B) 
DT or PBS was administration to langerin-DTR 
mice (described in the Materials and methods).  
24 h later CFSE-labeled CD45.1+V2+CD4+ OT-II 
cells were transferred and the mice were immunized 
with OVA/polyICLC. Representative flow cytom-
etry plots (A) and cumulative data from three 
experiments (B) are shown, comparing the ex-
pression of 47 on CFSElo CD45.1+V2+CD4+ 
OT-II cells. (C and D) CD45.1+V2+CD4+ OT-II cells 
were transferred to WT or batf3/ mice, fol-
lowed by immunized with OVA/polyICLC, delivered 
i.n. Representative flow cytometry plots (C) and 
cumulative data from three experiments (D) are 
shown, comparing the expression of 47 on 
CFSElo CD45.1+V2+CD4+ OT-II cells.
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Figure 10. i.n. immunization protects against enteric challenge with highly pathogenic Salmonella. (A–C) C56Bl/6 mice were immunized with 
OVA/polyICLC delivered i.n. or s.c. in a prime-boost fashion or p.o. with OVA/CT, and challenged orally 7 d after the boost with Salmonella-OVA. Unimmu-
nized mice challenged with Salmonella-OVA served as controls. Data from three independent experiments is presented here. (A) Kaplan-Meier curves 
comparing the survival of unimmunized (red) mice or mice immunized i.n. (green), s.c. (black), or p.o. (blue) against oral challenge with Salmonella-OVA 
(106PFU). (B) Hematoxylin and eosin sections examining the MLN (i, v, ix, and xiii), spleen (ii, vi, x, and xiv), and liver (iii, vii, xi, and xv), all at 200× magnifi-
cation (bar, 100 µm), and liver (iv, viii, xii, and xvi) at 400× magnification (bar, 50 µm) from a WT (unimmunized, unchallenged) mouse (i–iv), an unim-
munized, Salmonella-challenged mouse (v–viii), a representative i.n.-immunized, Salmonella-challenged mouse #1 (ix–xii), and a representative  
i.n.-immunized, Salmonella-challenged mouse #2 (xiii–xvi). (C) Cumulative data from three experiments showing the inflammation score from the WT 
(unimmunized, unchallenged), unimmunized, and Salmonella-challenged groups. (D) C56Bl/6 mice were immunized with heat and paraformaldehyde-
inactivated S. typhimurium delivered i.n. or s.c. in a prime-boost fashion, and challenged orally 7 d after the boost with Salmonella-OVA. Unimmunized 
mice challenged with Salmonella-OVA served as controls. CFU of S. typhimurium per gram of splenic tissue is compared between the WT, s.c.-immunized, 
and i.n.-immunized mice.
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and is associated with a striking absence of pathology in the 
liver and spleen in the immunized compared with unimmu­
nized mice.
DISCUSSION
In this study, we propose a novel pathway of lung DC–mediated 
T cell migration to the GI lamina propria via induction of 
gut­homing integrin 47. Several lines of evidence pointed 
us in this direction. First, lungs harbor extrahepatic stores of 
vitamin A (Okabe et al., 1984; Dirami et al., 2004). Second, 
lungs are anatomically juxtaposed to the liver (the largest store 
of vitamin A in the body), directly receiving hepatic blood. 
Third, lung DCs express the enzyme RALDH (Guilliams et al., 
2010) and are capable of oxidizing Vitamin A into RA. Thus, 
lung DCs have access to the necessary substrate (Vitamin A) 
and are equipped with the enzymatic machinery required to 
metabolize it and generate RA. These facts led us to hypothe­
size that lung DCs may up­regulate integrin 47 and in­
duce a gut­homing phenotype on T cells.
We have used multiple experimental approaches to 
test our hypothesis. First, lung DCs co­cultured with OVA­ 
specific OT­II cells in the presence of OVA express integrin 
47 at levels comparable to those induced by MLN CD103+ 
DCs. Second, integrin 47 is induced on adoptively trans­
ferred OT­II cells after i.n. immunization. Third, T cells can 
be tracked to the GI lamina propria after i.n. immunization 
and fourth, T cell migration can be blocked by anti­47 
antibody, causing the transferred T cells to accumulate in 
systemic compartments.
It may be argued that i.n. immunization may lead to inad­
vertent swallowing of antigen and targeting of GI­resident 
DCs that are known to induce gut migration of T and B cells. 
To exclude this possibility, we first used a time course experi­
ment to identify the populations targeted by i.n. delivery of 
fluorescent, DC­specific antibodies. We could readily detect 
targeting of mediastinal LN­ and lung­resident DCs, but not 
GI­resident DCs. Because this does not exclude migration of 
antigen to the GI tract, we performed experiments to block 
the egress of T cells from LNs using FTY­720. In doing so, we 
observed an accumulation of transferred cells in the mediasti­
nal LNs and, in contrast, a drop in transferred cell frequency 
in MLNs in mice given FTY­720, thereby confirming that 
i.n. immunization­mediated expansion of transferred cells 
was occurring in the former and not the latter lymphoid sites. 
Finally, we observed early (day 2) proliferation of transferred 
cells within the mediastinal LNs and the appearance of inte­
grin 47 on mediastinal LN­ and lung­resident cells (day 3), 
followed by the migration of transferred cells to GI compart­
ments (day 4), which could be blocked with an anti­47 
antibody. These data extend the work of Ciabattini et al. 
(2011), who recently demonstrated that after i.n. immuniza­
tion, antigen­specific T cells trafficked to distal skin­draining 
LNs in a CD62L­dependent fashion and to the MLNs in an 
47­dependent fashion. However, unlike in the present 
study, mechanisms of induction of 47, i.e., the role of lung 
DCs or the physiological relevance of these pathways was not 
explored by Ciabattini et al. (2011).
It is interesting to note that whereas migration to GI sites 
was blocked using an anti­47 antibody, migration to the 
systemic sites was not. In fact, there was a nonsignificant 
increase in the frequency of transferred cells in other sites 
examined, including the lungs. This lends specificity to our 
experimental approach, as migration of T cells to the lungs 
has been shown to be independent of 47/MAdCAM but 
dependent on l­Selectin/PNAd, 41/VCAM­1 and LFA­1 
(Xu et al., 2003).
To examine the role of lung DCs in the in vivo induction 
of integrin 47, we used two different conditional knock­
out models. Use of the CD11c DTR leads to the depletion of 
85–90% of CD11c+ DCs (Bennett and Clausen, 2007). How­
ever, because this model cannot distinguish between classical 
DCs, activated monocytes, and alveolar macrophages, all of 
which express CD11c and are therefore depleted (Probst et al., 
2005; Zammit et al., 2005), we also used the newly described 
zDC­DTR model (Meredith et al., 2012a,b). Significantly 
attenuated numbers of transferred congenic cells expressing 
47 were seen in both models, demonstrating that lung 
DCs induced integrin 47 after i.n. vaccination. These 
results need to be interpreted with the caveat that both 
DT­induced depletion of DCs and nasal administration of 
polyICLC are likely associated with lung inflammation (Tittel 
et al., 2012). We speculate that local inflammation is responsible 
for the variability observed in the levels of 47 expressed on 
transferred cells isolated from various compartments, the ex­
pression being high on cells isolated from the lungs compared 
with the cells isolated from the mediastinal LN and blood, or 
from the spleen and MLN (unpublished data), where a more 
profound attenuation of 47 was seen.
Thus, based on the data generated by different experi­
mental approaches, we propose that after i.n. immunization, 
lung and mediastinal LN­resident DCs are targeted which in 
turn induce the expression of integrin 47 on T cells, result­
ing in their localization to the GI tract. Herein, we provide 
novel functional evidence of mucosal cross talk mediated by 
DCs. This provides a mechanistic insight to the observation of 
T cell responses in the GI lamina propria after i.n. challenge 
(Esplugues et al., 2011; Masopust et al., 2010) or after the appear­
ance of antigen­specific T cells in the MLN after i.n. immu­
nization (Ciabattini et al., 2011).
Although the mechanisms underlying 47 induction 
appear to be conserved between lung­ and GI­resident DCs, 
the DC subsets involved show striking differences. For example, 
consistent with studies of 47 induction by gut DCs (Iwata 
et al., 2004; Kang et al., 2011), our results show that RA and 
TGF­ are required in the lung DC–mediated induction 
of 47. Notably, in addition to an in vitro culture system, 
we have used novel, dominant­negative RAR­OTII Rag/ 
mice and TGF­ receptorfl/fl­CD4CRE OT­II Rag/ mice to 
address these questions. Splenic OT­II cells from the dominant­
negative RAR­OTII Rag/ mice and TGF­ receptorfl/fl­
CD4CRE OT­II Rag/ mice were used as donor cells, so local 
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lung DC subsets in these mice are not relevant here. However, 
these mice will be described in detail in future studies.
In contrast to the existing literature showing that CD103+ 
MLN DCs induce integrin 47, whereas the CD11b+ MLN 
DCs do not, we have found that both CD103+ and CD11b+ 
lung DC populations induced integrin 47, the expression 
being higher in the lung CD11b+ DC induced co­cultures 
in vitro. Because these differences were novel and unexpected, 
we examined them by using in vivo DC depletion models. 
To deplete the CD103+ DC populations, we used Langerin DTR 
(Bennett et al., 2005) mice and could not detect any significant 
differences in the level of 47 induction between the lan­
gerin depleted and replete mice. To further confirm the effect 
of CD103+ DC depletion, we used the Batf3/ mice, in which 
the deletion of the transcription factor Batf3 results in ablation 
of cross presenting, CD103+ tissue DCs (Hildner et al., 2008). 
Again, no significant differences in the induction of 47 were 
observed between WT and Batf3/ animals. Finally, to deplete 
the CD11b+ lung DCs, we used the CD11b DTR mice. Both 
CD11b­expressing alveolar macrophages and DCs are depleted 
in this model; however, the use of zDC­DTR demonstrates the 
role of classical DCs. Attenuated levels of 47 were observed 
in the mice in which CD11b­expressing cells were depleted. It 
may be noted that although the dose of DT administered to the 
Langerin DTR and CD11b DTR mice was different, we were 
guided by previous studies on the dose required to deplete the 
respective DC subsets (Duffield et al., 2005; Kissenpfennig 
et al., 2005). Additionally, in this study, we confirmed the deple­
tion of respective lung DC populations. Therefore, in contrast 
with MLN DCs, both CD103+ and CD11b+ lung DC popula­
tions induced integrin 47 in vitro, although in vivo, the 
CD11b+ populations appeared to have a more dominant effect 
on the induction of 47. Furthermore, within the hetero­
geneous CD11b+ population, we observed a striking dif­
ference between the CD24+ and CD64+ subsets, where the 
CD24+CD11b+ DCs induced robust levels of 47 and 
CCR9, whereas CD64+CD11b+ cells did not. We speculate 
that whereas the migratory gut CD103+ DCs use dietary 
and biliary sources of vitamin A to generate RA ( Jaensson­ 
Gyllenbäck et al., 2011), the lung DCs either use hematoge­
nous vitamin A, released from hepatic stores, or local stores of 
vitamin A (Dirami et al., 2004; Okabe et al., 1984). Thus, the 
predominance of CD103+ DC in mediating gut­homing, as 
in the case of MLN, is not observed in case of lung DCs. 
This further allows us to speculate that specific DC populations, 
i.e., CD103+ DCs, may not be preconditioned to metabolize 
vitamin A but rather, they may acquire this property based on 
local environmental factors like the availability of vitamin A, 
TLR ligands, or other inflammatory stimuli. Detailed mechanis­
tic studies are underway to further address this question, includ­
ing a study of the relative expression of RALDH and the effect 
of adjuvants on RALDH expression by lung DC subsets.
Integrins may be induced via nonspecific stimuli, such as 
cellular activation (Laudanna et al., 2002). Because our in vivo 
experimental system involved use of the TLR­3 agonist, poly­
ICLC, we tested its effect on the induction of integrin 47. 
Initially, we used polyICLC alone (without antigen) but could 
not observe any significant induction of 47, whereas OVA 
alone induced 47 on transferred OTII cells. In addition, 
using the MDA5/TLR3/ mice, we were able to confirm 
that i.n. immunization­induced 47 was not a nonspecific 
effect of adjuvant. Additionally, we have tested the use of differ­
ent adjuvants in the induction of 47 after i.n. immunization 
and observed no significant differences between them (unpub­
lished data). Combined, we speculate that in the right cellular 
context, i.e., in the presence of local availability of RA and 
TGF­, the use of an adjuvant amplifies the induction of 47 
because of DC and T cell activation, as well as DC migration.
Having shown that lung DCs induce 47 and induce 
cellular migration to the GI tract, we wanted to study if 
pathogen­specific intestinal immunity can be induced by tar­
geting lung DCs. We chose Salmonella typhimurium, a patho­
gen of global significance (Levine, 2006) that is transmitted 
across the intestinal mucosa and causes a spectrum of diseases 
ranging from localized intestinal infection to severe systemic 
illness (Griffin and McSorley, 2011). Notably, although Salmo-
nella is not a lung pathogen, we used this model as a tool to 
examine i.n. vaccine induced protection against Salmonella  
invasion across the GI tract. To confirm protection against 
enteric challenge with Salmonella , we have used three different 
experimental systems: (1) passive immunization using trans­
ferred OT­II cells followed by i.n. immunization, where 
we demonstrated a modest increase in survival; (2) active 
prime­boost immunization with OVA showing a signifi­
cantly increased survival and lack of systemic pathology in the 
i.n.­immunized mice; and (3) active prime­boost immuniza­
tion using inactivated Salmonella showing reduced systemic 
burden in the i.n.­immunized mice. Thus, using multiple 
experimental systems, we were able to show that lung DCs 
targeted by i.n. immunization are able to induce protective 
immunity within the GI tract. Notably, in mice that received 
s.c. vaccine, a nonsignificant increase in survival was also ob­
served. We hypothesize this to be due to the systemic immu­
nity generated by s.c. vaccine and plan to study this further 
with the use of IgA­deficient, CD103/ and B7/ mice.
To conclude, in this manuscript we challenge the dogma 
that only CD103+ gut­resident DCs can recruit T cells to the 
GI tract. Rather, we provide compelling evidence that lung 
DCs targeted by i.n. immunization are capable of inducing 
robust levels of gut­homing integrin 47 and licensing 
T cells to migrate to the GI tract. Pathways of recruitment 
of antigen­specific immune cells to the gut are therefore 
much more promiscuous than previously appreciated. There 
appears to be considerable, albeit hitherto unrecognized, DC­
orchestrated, mucosal cross talk that can inform the rational 
design of novel vaccines.
MATERIALS AND METHODS
Mice. C57BL/6 (B6), C57BL/6­Tg(TcraTcrb)425Cbn/J (OT­II), and 
C57BL/6­Tg(TcraTcrb)1100MjbJ (OT­I) mice were purchased from Taconic 
Farms or bred at The Rockefeller University. 6–8­wk­old CD11c­DTR 
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(B6.FVB­Tg(Itgax­DTR/EGFP)57Lan/J) mice were purchased from The 
Jackson Laboratory. CD4CRETGF­Rfl/fl OT­II mice and the dnRAR­OT­II 
mice were provided by the Mucida Laboratory (The Rockefeller University, 
New York, NY). In brief, CD4CRE mice were crossed with TGF­Rfl/fl  
mice (provided to the Mucida laboratory by the National Cancer Institute, 
Rockville MD) to specifically deplete TGF­R from CD4 T cells. To avoid 
autoimmune disease and premature death in CD4CRE x TGF­Rfl/fl mice, 
these animals were backcrossed to OT­II Rag/ animals to obtain TGF­Rdef 
OT­II (TGF­Rdef) mice (these mice will be described elsewhere). To analyze 
RA signaling in CD4+ T cells, CD4CRE mice were crossed with dnRARfl/fl 
mice(Pino­Lagos et al., 2011; Rajaii et al., 2008) to specifically express the 
dominant­negative form of RAR in CD4+ T cells. To address the importance 
of RA for mucosal T cell migration after specific T cell activation, these ani­
mals were backcrossed to an OT­II Rag/ background. MDA­5/TLR3/ 
mice (McCartney et al., 2009) were provided by M. Colonna (Washington 
University, St. Louis, MO).
Bone marrow chimeras were created by transferring bone marrow from 
CD11c­DTR, zDC­DTR, and CD11b DTR mice into lethally irradiated 
WT C57BL/6 mice to avoid lethality associated with DT treatments of 
CD11c­DTR (Jung et al., 2002; Zammit et al., 2005), zDC­DTR (Meredith 
et al., 2012a), or CD11b DTR. In brief, C57BL/6 hosts underwent two 
treatments of 500 rads in an animal ­irradiator 3­h apart, and 2.5 × 106 
bone marrow cells from CD11c­DTR, zDC­DTR, and CD11b­DTR donor, 
respectively, were transferred i.v. The resulting mice (referred to herein as 
CD11c­DTR, zDC­DTR, and CD11b­DTR) were housed under immuno­
compromised mouse conditions and treated regularly with 2 mg/ml neomycin 
from Sigma­Aldrich in their drinking water. The chimeric mice were fully 
reconstituted and ready for experimental use after 6 wk.
Mice were maintained in specific pathogen–free conditions. Pro­
tocols were approved by the The Rockefeller University Animal Care and 
Use Committee.
Antibodies. The following reagents were purchased from BD: anti­CD3 
(500A2), anti­CD3 (145–2011), anti­CD103 (M290), anti­CD4 (RM4­5), 
and anti­CD8 (53–6.9). The following reagents were purchased from eBio­
science: anti­MHCII (M5/114.15.2), anti­IFN­ (XMG1.2), anti­CD4 
(RM4­5), and anti­CD8 (53–6.9). The following antibodies were obtained from 
BioLegend: anti­CD45 (30­F11), anti­CD45.1 (A20), anti­CD45.2 anti­CD11c 
(N418), anti­CD11b (M1/70), anti­IFN­ (XMG1.2), anti­CD103 (M290), 
anti­LPAM­1 (DATK32), anti­CD24 (M1/6a), anti­CCR9 (CW12), anti­CD64 
(X54­51711), and anti­TCRV2 (B20.1). AQUA (L34957) was obtained from 
Invitrogen, and CFSE was purchased from Sigma. Anti­CD205 (NLDCC) was 
produced locally, as previously described (Trumpfheller et al., 2006).
Adoptive cell transfer. OT­I or OT­II mice were used as cell donors for 
adoptive transfer into syngeneic recipient animals. Lymphocytes were iso­
lated from the spleen and labeled with 5 µM CFSE (Invitrogen) for 10 min 
at 37°C. After washing twice with PBS containing 3% FCS, 7 × 106 cells per 
mouse were injected via the retroorbital venous plexus.
Immunization. CFSE­labeled OT­I or OT­II mice were adoptively trans­
ferred into syngeneic age­ and gender­matched WT mice and controls. 2 h 
later, the recipient mice were immunized i.n., i.t., or s.c. with 100 µg OVA 
(LPS­free; Seikagaku Corp.) and 50 µg of poly ICLC (Oncovir, Inc.) using 
Isoflurane as a short­acting inhalant anesthetic. Additionally, recipient mice 
were immunized p.o. with 50 mg of OVA (Grade III; Sigma­Aldrich) and 
2 µg of cholera toxin (Sigma­Aldrich). All animals were given food and 
water ad libitum.
Tissue harvesting and cell preparation. Mice were euthanized and 
blood was obtained from the experimental mice by cardiac puncture. Lung 
mononuclear cell isolation was performed as previously described (Vermaelen 
et al., 2001). In brief, after sacrificing the animals, the pulmonary circulation 
was perfused with saline to remove the intravascular pool of cells. Lungs were 
carefully separated from thymic and cardiovascular remnants and removed in 
toto. Organs were thoroughly minced using iridectomy scissors and incu­
bated for 60 min in digestion medium containing collagenase D in a humidi­
fied incubator at 37°C and 5% CO2. In the last 5 min, 10 mM EDTA was 
added. Tissue fragments were disrupted mechanically by pipetting and passed 
through a 70­µm cell strainer. Mononuclear cells were washed twice in 
RPMI before use in subsequent experiments as described below.
The spleen and LN were harvested in RPMI media with 5% FCS, 
mashed between two sterile glass slides, washed with RPMI complete media, 
and then filtered through a 70­µm filter. Spleen but not LN samples went 
through subsequent ACK lysis, were washed twice, and counted. LN single­
cell suspensions were prepared by incubation with 400 U/ml collagenase D 
at 37°C for 30 min.
Intestinal lymphocytes were isolated and prepared as previously de­
scribed (Mucida et al., 2007). In brief, small and large intestines were re­
moved and placed in cold HBSS media containing 5% FCS. The intestines 
were carefully cleaned from the mesentery and flushed of fecal content. 
Intestines were opened longitudinally and then cut into 1­cm pieces. The 
intestinal tissue was incubated with 1.3 mM EDTA (Cellgro) in HBSS at 
37°C for 1 h. The supernatants containing intestinal epithelial cell (IEC) with 
some superficial villi cells, referred to as the “IEC fraction,” were collected 
and layered over a discontinuous 40/80% Percoll gradient, and centrifuged at 
2,800 rpm for 30 min. Cells from the 40/80% interface were collected, 
washed, and resuspended in complete RPMI media. These purified cells 
constituted the intraepithelial lymphocyte (IEL) population. To isolate the 
lamina propria lymphocytes (LPL), the remaining intestinal tissue was minced 
and transferred to conical tubes. The minced pieces were resuspended in 
20 ml of complete RPMI containing 0.125 mg/ml of collagenase (Sigma­
Aldrich) and shaken at 200 rpm for 50 min at 37°C. The tissue suspension 
was collected and passed through a 70­µm cell strainer and the cells were 
pelleted by centrifugation at 1,200 rpm. The cells were then resuspended and 
layered onto a 40/80% Percoll gradient, centrifuged, and processed as de­
scribed above for the IEL preparation.
DC isolation. Single­cell suspensions were isolated from the murine lung, 
spleen, mesenteric, mediastinal, and skin­draining LNs as described above. 
CD11c+ cells were isolated as previously described (Ing et al., 2006) using 
CD11c magnetic beads (Miltenyi Biotec). In brief, the cells were washed in 
1 ml of MACS buffer (Miltenyi Biotec), before 30­min incubation on ice with 
CD11c+ beads. The cellular suspensions were washed twice in MACS buffer 
and passed through a magnetic column. CD11c+ cells were isolated by positive 
selection, washed, resuspended in complete RPMI medium, and counted be­
fore co­culture with T cells, as described in the following section.
Lung DC subset isolation. Lung mononuclear cells were isolated as 
described above. Using magnetic beads, CD11c+ cells were enriched and 
sorted on FACSAria (BD) as B220MHC II+CD11chiCD103+CD11b and 
B220MHC II+CD11chiCD103CD11b+ subsets.
In vitro DC/T cell co-cultures. The culture medium used for DC/T cell 
cultures was RPMI (Invitrogen) supplemented with 10% heat­inactivated 
FCS, 2 mM l­glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 
5 mM ­mercaptoethanol (all from Sigma­Aldrich). Allogeneic T cells were 
isolated from spleens of C57BL/6 mice by excluding B220+, F4/80+, 
CD49b+, and I­Ab+ cells with anti–rat IgG Dynabeads (Invitrogen). T cells 
were added to round­bottom microtest wells at 105/well and mixed with 
isolated DCs at a DC/T cell ratio of 1:2, 1:5, and 1:10 in the presence of 
OVA (25 µg/ml final). After 5 d, the expression of 47 on proliferating 
T cells was evaluated by FACS. For the retinoic acid inhibition assays, the 
DC/T cell co­cultures were incubated with 1 µM of RAR­ antagonist, 
LE540 (Wako; dissolved in DMSO at a stock concentration of 1 mM), and 
added to cultures at final concentration of 1 µM.
Flow cytometric analyses, intracellular staining and gating schema. 
Cells were isolated as described in the preceeding section. Before staining, 
cells were washed and resuspended in staining buffer containing 1× PBS, 
2% BSA, 10 mM EDTA, and 0.01% NaN3. To block nonspecific staining, 
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the 2.4G2 anti­CD16/32 antibody was added. Antibodies for cell surface 
markers were added and cells were incubated for 25 min at 4°C. After the 
staining, the cells were washed twice and analyzed immediately or fixed in 
PBS containing 1% paraformaldehyde and 0.01% NaN3, and analyzed later 
on an LSR II (BD) using multiparameter flow cytometry.
For intracellular cytokine staining, after surface staining, cells were resus­
pended in Fixation/Permeabilization solution (Cytofix/Cytoperm kit; BD), 
and intracellular cytokine staining was performed according to the manufac­
turer’s protocol. Flow cytometric data were analyzed with FlowJo software 
(Tree Star). For analysis of the adoptively transferred OT­I and OT­II popula­
tions, the transferred cells were identified by forward and side scatter character­
istics and dead cells were excluded using Live­dead fixable Aqua (Invitrogen), 
followed by sequential gating on CD45.1+, CD3+, CD4+V2+ double­positive 
populations followed by the expression of 47 on CFSElo cells.
ALDEFLUOR assay. ALDH activity was determined using the ALDE­
FLUOR staining kit (STEMCELL Technologies) according to the manu­
facturer’s instructions, with some modifications. In brief, LN and lung 
mononuclear cells were resuspended at 106 cells/ml in ALDEFLUOR assay 
buffer containing activated ALDEFLUOR substrate (final concentration, 
1.5 µM) with or without the aldehyde dehydrogenase inhibitor DEAB (final 
concentration, 45 µM) and incubated for 30 min at 37°C. For immunophe­
notyping of ALDEFLUOR­reactive cells, the cells were subsequently stained 
with PE­, PE­Cy7–, A700­, PerCP Cy5.5­, and Pacific blue–conjugated 
mAbs in ice­cold ALDEFLUOR assay buffer. ALDEFLUOR­reactive cells 
were detected in the FITC channel using multi­parameter flow cytometry, as 
described above.
In vivo DT treatment. DT purchased from Sigma­Aldrich was prepared 
in a sterile solution of PBS at a concentration of 1 mg/ml. Transient DC de­
pletion was effected in CD11c­DTR chimeras by a single i.p. injection of 
200 ng DT; in zDC­DTR mice, a single 100­ng i.p. injection of DT was 
given i.p.; in CD11b­DTR mice, two 500­ng injections were given on days 0 
and 1 i.p.; and in langerin DTR mice, a single dose of 100 ng of DT was 
given i.p.
Salmonella challenge. Recipients of adoptively transferred OT­II cells, mice 
immunized i.n. or s.c. with OVA, and mice immunized with heat inactivated, 
paraformaldehyde­fixed Salmonella (106 CFU) were inoculated orally by ga­
vage with WT Salmonella­OVA (106 CFU/animal). Mice were monitored with 
recording of daily weights. Stool culture was performed by culturing pre­
weighed stool pellets on days 2, 4, 8, 12, and 40 after challenge (day 40 stool 
cultures were performed in the long­term survivors to detect for persistence 
of Salmonella in the stool) and expressed as Salmonella CFU/g of stool tissue. 
For splenic cultures, the spleen was harvested from the Salmonella­challenged 
mice on day 6 after challenge, and then weighed, ground in LB broth, and in­
oculated on Macconkey’s Agar in serial dilutions. Kaplan­Meier curves were 
used to determine the frequency of survival among the challenged mice.
Statistical analysis. Statistical significance was evaluated using a two­tailed 
Student’s t test with a 95% confidence interval. Results are expressed as 
means ± SD. Analysis was performed with a Prism 4 program (GraphPad 
Software, Inc.).
Online supplemental material. Fig. S1 shows the gating strategy used 
to identify and sort lung DCs. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20122762/DC1.
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